Australia markets closed

QURE Oct 2022 22.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.90000.0000 (0.00%)
As of 12:40PM EDT. Market open.
Full screen
Previous close1.9000
Open1.9000
Bid1.7500
Ask2.2000
Strike22.50
Expiry date2022-10-21
Day's range1.9000 - 1.9000
Contract rangeN/A
Volume2
Open interest366
  • Motley Fool

    Why uniQure Stock Is Crashing Today

    Shares of uniQure N.V. (NASDAQ: QURE) are crashing today, down by 32.6% as of 11:19 a.m. ET. The steep decline came after the gene therapy specialist provided its second-quarter update Monday morning. Investors weren't all that interested in uniQure's financial results.

  • Zacks

    UniQure (QURE) Reports Q2 Loss, Lags Revenue Estimates

    uniQure (QURE) delivered earnings and revenue surprises of 12.50% and 97.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    uniQure Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress

    ~ Announced 12-month data on the lower-dose cohort of AMT-130 in Huntington’s disease showed the investigative gene therapy was generally well tolerated at this dose with a mean reduction of 53.8% of mutant Huntingtin protein (mHTT) observed in cerebral spinal fluid (CSF) ~ ~ Announced postponement of AMT-130 higher-dose procedures due to recent suspected unexpected severe adverse reactions at this dose; Lower-dose procedures are not affected and no impact is expected on anticipated data readout